img

Global Opioid Analgesics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Opioid Analgesics Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Opioid Analgesics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Opioid Analgesics market research.
Key manufacturers engaged in the Opioid Analgesics industry include Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH and Bausch Health, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Opioid Analgesics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Opioid Analgesics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Opioid Analgesics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer Inc.
Abbott Laboratories
Johnson & Johnson
Novartis AG
Bayer AG
GlaxoSmithKline plc
F. Hoffmann-La Roche AG
Boehringer Ingelheim International GmbH
Bausch Health
Sanofi S.A.
Teva Pharmaceuticals
Purdue Pharmaceuticals L.P.
Endo International Plc
Assertio Holdings, Inc
Segment by Type
OxyContin
Vicodin
Morphine
Methadone
Others

Segment by Application


Surgical Pain
Cancer Pain
Neuropathic Pain
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Opioid Analgesics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Opioid Analgesics Market Overview
1.1 Product Overview and Scope of Opioid Analgesics
1.2 Opioid Analgesics Segment by Type
1.2.1 Global Opioid Analgesics Market Value Comparison by Type (2024-2034)
1.2.2 OxyContin
1.2.3 Vicodin
1.2.4 Morphine
1.2.5 Methadone
1.2.6 Others
1.3 Opioid Analgesics Segment by Application
1.3.1 Global Opioid Analgesics Market Value by Application: (2024-2034)
1.3.2 Surgical Pain
1.3.3 Cancer Pain
1.3.4 Neuropathic Pain
1.3.5 Others
1.4 Global Opioid Analgesics Market Size Estimates and Forecasts
1.4.1 Global Opioid Analgesics Revenue 2024-2034
1.4.2 Global Opioid Analgesics Sales 2024-2034
1.4.3 Global Opioid Analgesics Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Opioid Analgesics Market Competition by Manufacturers
2.1 Global Opioid Analgesics Sales Market Share by Manufacturers (2024-2024)
2.2 Global Opioid Analgesics Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Opioid Analgesics Average Price by Manufacturers (2024-2024)
2.4 Global Opioid Analgesics Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Opioid Analgesics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioid Analgesics, Product Type & Application
2.7 Opioid Analgesics Market Competitive Situation and Trends
2.7.1 Opioid Analgesics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Opioid Analgesics Players Market Share by Revenue
2.7.3 Global Opioid Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioid Analgesics Retrospective Market Scenario by Region
3.1 Global Opioid Analgesics Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Opioid Analgesics Global Opioid Analgesics Sales by Region: 2024-2034
3.2.1 Global Opioid Analgesics Sales by Region: 2024-2024
3.2.2 Global Opioid Analgesics Sales by Region: 2024-2034
3.3 Global Opioid Analgesics Global Opioid Analgesics Revenue by Region: 2024-2034
3.3.1 Global Opioid Analgesics Revenue by Region: 2024-2024
3.3.2 Global Opioid Analgesics Revenue by Region: 2024-2034
3.4 North America Opioid Analgesics Market Facts & Figures by Country
3.4.1 North America Opioid Analgesics Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Opioid Analgesics Sales by Country (2024-2034)
3.4.3 North America Opioid Analgesics Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Opioid Analgesics Market Facts & Figures by Country
3.5.1 Europe Opioid Analgesics Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Opioid Analgesics Sales by Country (2024-2034)
3.5.3 Europe Opioid Analgesics Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioid Analgesics Market Facts & Figures by Country
3.6.1 Asia Pacific Opioid Analgesics Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Opioid Analgesics Sales by Country (2024-2034)
3.6.3 Asia Pacific Opioid Analgesics Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Opioid Analgesics Market Facts & Figures by Country
3.7.1 Latin America Opioid Analgesics Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Opioid Analgesics Sales by Country (2024-2034)
3.7.3 Latin America Opioid Analgesics Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Opioid Analgesics Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioid Analgesics Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Opioid Analgesics Sales by Country (2024-2034)
3.8.3 Middle East and Africa Opioid Analgesics Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Opioid Analgesics Sales by Type (2024-2034)
4.1.1 Global Opioid Analgesics Sales by Type (2024-2024)
4.1.2 Global Opioid Analgesics Sales by Type (2024-2034)
4.1.3 Global Opioid Analgesics Sales Market Share by Type (2024-2034)
4.2 Global Opioid Analgesics Revenue by Type (2024-2034)
4.2.1 Global Opioid Analgesics Revenue by Type (2024-2024)
4.2.2 Global Opioid Analgesics Revenue by Type (2024-2034)
4.2.3 Global Opioid Analgesics Revenue Market Share by Type (2024-2034)
4.3 Global Opioid Analgesics Price by Type (2024-2034)
5 Segment by Application
5.1 Global Opioid Analgesics Sales by Application (2024-2034)
5.1.1 Global Opioid Analgesics Sales by Application (2024-2024)
5.1.2 Global Opioid Analgesics Sales by Application (2024-2034)
5.1.3 Global Opioid Analgesics Sales Market Share by Application (2024-2034)
5.2 Global Opioid Analgesics Revenue by Application (2024-2034)
5.2.1 Global Opioid Analgesics Revenue by Application (2024-2024)
5.2.2 Global Opioid Analgesics Revenue by Application (2024-2034)
5.2.3 Global Opioid Analgesics Revenue Market Share by Application (2024-2034)
5.3 Global Opioid Analgesics Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Pfizer Inc. Opioid Analgesics Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Abbott Laboratories Opioid Analgesics Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Johnson & Johnson Opioid Analgesics Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Novartis AG Opioid Analgesics Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Bayer AG Opioid Analgesics Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 GlaxoSmithKline plc
6.6.1 GlaxoSmithKline plc Corporation Information
6.6.2 GlaxoSmithKline plc Description and Business Overview
6.6.3 GlaxoSmithKline plc Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.6.4 GlaxoSmithKline plc Opioid Analgesics Product Portfolio
6.6.5 GlaxoSmithKline plc Recent Developments/Updates
6.7 F. Hoffmann-La Roche AG
6.6.1 F. Hoffmann-La Roche AG Corporation Information
6.6.2 F. Hoffmann-La Roche AG Description and Business Overview
6.6.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.4.4 F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio
6.7.5 F. Hoffmann-La Roche AG Recent Developments/Updates
6.8 Boehringer Ingelheim International GmbH
6.8.1 Boehringer Ingelheim International GmbH Corporation Information
6.8.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.8.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio
6.8.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.9 Bausch Health
6.9.1 Bausch Health Corporation Information
6.9.2 Bausch Health Description and Business Overview
6.9.3 Bausch Health Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Bausch Health Opioid Analgesics Product Portfolio
6.9.5 Bausch Health Recent Developments/Updates
6.10 Sanofi S.A.
6.10.1 Sanofi S.A. Corporation Information
6.10.2 Sanofi S.A. Description and Business Overview
6.10.3 Sanofi S.A. Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Sanofi S.A. Opioid Analgesics Product Portfolio
6.10.5 Sanofi S.A. Recent Developments/Updates
6.11 Teva Pharmaceuticals
6.11.1 Teva Pharmaceuticals Corporation Information
6.11.2 Teva Pharmaceuticals Opioid Analgesics Description and Business Overview
6.11.3 Teva Pharmaceuticals Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Teva Pharmaceuticals Opioid Analgesics Product Portfolio
6.11.5 Teva Pharmaceuticals Recent Developments/Updates
6.12 Purdue Pharmaceuticals L.P.
6.12.1 Purdue Pharmaceuticals L.P. Corporation Information
6.12.2 Purdue Pharmaceuticals L.P. Opioid Analgesics Description and Business Overview
6.12.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio
6.12.5 Purdue Pharmaceuticals L.P. Recent Developments/Updates
6.13 Endo International Plc
6.13.1 Endo International Plc Corporation Information
6.13.2 Endo International Plc Opioid Analgesics Description and Business Overview
6.13.3 Endo International Plc Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Endo International Plc Opioid Analgesics Product Portfolio
6.13.5 Endo International Plc Recent Developments/Updates
6.14 Assertio Holdings, Inc
6.14.1 Assertio Holdings, Inc Corporation Information
6.14.2 Assertio Holdings, Inc Opioid Analgesics Description and Business Overview
6.14.3 Assertio Holdings, Inc Opioid Analgesics Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Assertio Holdings, Inc Opioid Analgesics Product Portfolio
6.14.5 Assertio Holdings, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioid Analgesics Industry Chain Analysis
7.2 Opioid Analgesics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioid Analgesics Production Mode & Process
7.4 Opioid Analgesics Sales and Marketing
7.4.1 Opioid Analgesics Sales Channels
7.4.2 Opioid Analgesics Distributors
7.5 Opioid Analgesics Customers
8 Opioid Analgesics Market Dynamics
8.1 Opioid Analgesics Industry Trends
8.2 Opioid Analgesics Market Drivers
8.3 Opioid Analgesics Market Challenges
8.4 Opioid Analgesics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Opioid Analgesics Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Opioid Analgesics Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Opioid Analgesics Market Competitive Situation by Manufacturers in 2022
Table 4. Global Opioid Analgesics Sales (K Tons) of Key Manufacturers (2024-2024)
Table 5. Global Opioid Analgesics Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Opioid Analgesics Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Opioid Analgesics Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Opioid Analgesics Average Price (US$/Ton) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Opioid Analgesics, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Opioid Analgesics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Opioid Analgesics, Product Type & Application
Table 12. Global Key Manufacturers of Opioid Analgesics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Opioid Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Analgesics as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Opioid Analgesics Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Opioid Analgesics Sales by Region (2024-2024) & (K Tons)
Table 18. Global Opioid Analgesics Sales Market Share by Region (2024-2024)
Table 19. Global Opioid Analgesics Sales by Region (2024-2034) & (K Tons)
Table 20. Global Opioid Analgesics Sales Market Share by Region (2024-2034)
Table 21. Global Opioid Analgesics Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Opioid Analgesics Revenue Market Share by Region (2024-2024)
Table 23. Global Opioid Analgesics Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Opioid Analgesics Revenue Market Share by Region (2024-2034)
Table 25. North America Opioid Analgesics Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Opioid Analgesics Sales by Country (2024-2024) & (K Tons)
Table 27. North America Opioid Analgesics Sales by Country (2024-2034) & (K Tons)
Table 28. North America Opioid Analgesics Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Opioid Analgesics Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Opioid Analgesics Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Opioid Analgesics Sales by Country (2024-2024) & (K Tons)
Table 32. Europe Opioid Analgesics Sales by Country (2024-2034) & (K Tons)
Table 33. Europe Opioid Analgesics Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Opioid Analgesics Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Opioid Analgesics Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Opioid Analgesics Sales by Region (2024-2024) & (K Tons)
Table 37. Asia Pacific Opioid Analgesics Sales by Region (2024-2034) & (K Tons)
Table 38. Asia Pacific Opioid Analgesics Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Opioid Analgesics Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Opioid Analgesics Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Opioid Analgesics Sales by Country (2024-2024) & (K Tons)
Table 42. Latin America Opioid Analgesics Sales by Country (2024-2034) & (K Tons)
Table 43. Latin America Opioid Analgesics Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Opioid Analgesics Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Opioid Analgesics Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Opioid Analgesics Sales by Country (2024-2024) & (K Tons)
Table 47. Middle East & Africa Opioid Analgesics Sales by Country (2024-2034) & (K Tons)
Table 48. Middle East & Africa Opioid Analgesics Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Opioid Analgesics Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Opioid Analgesics Sales (K Tons) by Type (2024-2024)
Table 51. Global Opioid Analgesics Sales (K Tons) by Type (2024-2034)
Table 52. Global Opioid Analgesics Sales Market Share by Type (2024-2024)
Table 53. Global Opioid Analgesics Sales Market Share by Type (2024-2034)
Table 54. Global Opioid Analgesics Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Opioid Analgesics Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Opioid Analgesics Revenue Market Share by Type (2024-2024)
Table 57. Global Opioid Analgesics Revenue Market Share by Type (2024-2034)
Table 58. Global Opioid Analgesics Price (US$/Ton) by Type (2024-2024)
Table 59. Global Opioid Analgesics Price (US$/Ton) by Type (2024-2034)
Table 60. Global Opioid Analgesics Sales (K Tons) by Application (2024-2024)
Table 61. Global Opioid Analgesics Sales (K Tons) by Application (2024-2034)
Table 62. Global Opioid Analgesics Sales Market Share by Application (2024-2024)
Table 63. Global Opioid Analgesics Sales Market Share by Application (2024-2034)
Table 64. Global Opioid Analgesics Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Opioid Analgesics Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Opioid Analgesics Revenue Market Share by Application (2024-2024)
Table 67. Global Opioid Analgesics Revenue Market Share by Application (2024-2034)
Table 68. Global Opioid Analgesics Price (US$/Ton) by Application (2024-2024)
Table 69. Global Opioid Analgesics Price (US$/Ton) by Application (2024-2034)
Table 70. Pfizer Inc. Corporation Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 73. Pfizer Inc. Opioid Analgesics Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. Abbott Laboratories Corporation Information
Table 76. Abbott Laboratories Description and Business Overview
Table 77. Abbott Laboratories Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 78. Abbott Laboratories Opioid Analgesics Product
Table 79. Abbott Laboratories Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 83. Johnson & Johnson Opioid Analgesics Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 88. Novartis AG Opioid Analgesics Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Bayer AG Corporation Information
Table 91. Bayer AG Description and Business Overview
Table 92. Bayer AG Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 93. Bayer AG Opioid Analgesics Product
Table 94. Bayer AG Recent Developments/Updates
Table 95. GlaxoSmithKline plc Corporation Information
Table 96. GlaxoSmithKline plc Description and Business Overview
Table 97. GlaxoSmithKline plc Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 98. GlaxoSmithKline plc Opioid Analgesics Product
Table 99. GlaxoSmithKline plc Recent Developments/Updates
Table 100. F. Hoffmann-La Roche AG Corporation Information
Table 101. F. Hoffmann-La Roche AG Description and Business Overview
Table 102. F. Hoffmann-La Roche AG Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 103. F. Hoffmann-La Roche AG Opioid Analgesics Product
Table 104. F. Hoffmann-La Roche AG Recent Developments/Updates
Table 105. Boehringer Ingelheim International GmbH Corporation Information
Table 106. Boehringer Ingelheim International GmbH Description and Business Overview
Table 107. Boehringer Ingelheim International GmbH Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 108. Boehringer Ingelheim International GmbH Opioid Analgesics Product
Table 109. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 110. Bausch Health Corporation Information
Table 111. Bausch Health Description and Business Overview
Table 112. Bausch Health Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 113. Bausch Health Opioid Analgesics Product
Table 114. Bausch Health Recent Developments/Updates
Table 115. Sanofi S.A. Corporation Information
Table 116. Sanofi S.A. Description and Business Overview
Table 117. Sanofi S.A. Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 118. Sanofi S.A. Opioid Analgesics Product
Table 119. Sanofi S.A. Recent Developments/Updates
Table 120. Teva Pharmaceuticals Corporation Information
Table 121. Teva Pharmaceuticals Description and Business Overview
Table 122. Teva Pharmaceuticals Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 123. Teva Pharmaceuticals Opioid Analgesics Product
Table 124. Teva Pharmaceuticals Recent Developments/Updates
Table 125. Purdue Pharmaceuticals L.P. Corporation Information
Table 126. Purdue Pharmaceuticals L.P. Description and Business Overview
Table 127. Purdue Pharmaceuticals L.P. Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 128. Purdue Pharmaceuticals L.P. Opioid Analgesics Product
Table 129. Purdue Pharmaceuticals L.P. Recent Developments/Updates
Table 130. Endo International Plc Corporation Information
Table 131. Endo International Plc Description and Business Overview
Table 132. Endo International Plc Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 133. Endo International Plc Opioid Analgesics Product
Table 134. Endo International Plc Recent Developments/Updates
Table 135. Assertio Holdings, Inc Corporation Information
Table 136. Assertio Holdings, Inc Description and Business Overview
Table 137. Assertio Holdings, Inc Opioid Analgesics Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 138. Assertio Holdings, Inc Opioid Analgesics Product
Table 139. Assertio Holdings, Inc Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Opioid Analgesics Distributors List
Table 143. Opioid Analgesics Customers List
Table 144. Opioid Analgesics Market Trends
Table 145. Opioid Analgesics Market Drivers
Table 146. Opioid Analgesics Market Challenges
Table 147. Opioid Analgesics Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioid Analgesics
Figure 2. Global Opioid Analgesics Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Opioid Analgesics Market Share by Type in 2022 & 2034
Figure 4. OxyContin Product Picture
Figure 5. Vicodin Product Picture
Figure 6. Morphine Product Picture
Figure 7. Methadone Product Picture
Figure 8. Others Product Picture
Figure 9. Global Opioid Analgesics Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Opioid Analgesics Market Share by Application in 2022 & 2034
Figure 11. Surgical Pain
Figure 12. Cancer Pain
Figure 13. Neuropathic Pain
Figure 14. Others
Figure 15. Global Opioid Analgesics Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 16. Global Opioid Analgesics Market Size (2024-2034) & (US$ Million)
Figure 17. Global Opioid Analgesics Sales (2024-2034) & (K Tons)
Figure 18. Global Opioid Analgesics Average Price (US$/Ton) & (2024-2034)
Figure 19. Opioid Analgesics Report Years Considered
Figure 20. Opioid Analgesics Sales Share by Manufacturers in 2022
Figure 21. Global Opioid Analgesics Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Opioid Analgesics Players: Market Share by Revenue in 2022
Figure 23. Opioid Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 24. Global Opioid Analgesics Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 25. North America Opioid Analgesics Sales Market Share by Country (2024-2034)
Figure 26. North America Opioid Analgesics Revenue Market Share by Country (2024-2034)
Figure 27. United States Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Canada Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Europe Opioid Analgesics Sales Market Share by Country (2024-2034)
Figure 30. Europe Opioid Analgesics Revenue Market Share by Country (2024-2034)
Figure 31. Germany Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. France Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. U.K. Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Italy Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Russia Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Asia Pacific Opioid Analgesics Sales Market Share by Region (2024-2034)
Figure 37. Asia Pacific Opioid Analgesics Revenue Market Share by Region (2024-2034)
Figure 38. China Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Japan Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. South Korea Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. India Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Australia Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. China Taiwan Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Indonesia Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Thailand Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Malaysia Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Latin America Opioid Analgesics Sales Market Share by Country (2024-2034)
Figure 48. Latin America Opioid Analgesics Revenue Market Share by Country (2024-2034)
Figure 49. Mexico Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Brazil Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Argentina Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Opioid Analgesics Sales Market Share by Country (2024-2034)
Figure 53. Middle East & Africa Opioid Analgesics Revenue Market Share by Country (2024-2034)
Figure 54. Turkey Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Saudi Arabia Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 56. UAE Opioid Analgesics Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Opioid Analgesics by Type (2024-2034)
Figure 58. Global Revenue Market Share of Opioid Analgesics by Type (2024-2034)
Figure 59. Global Opioid Analgesics Price (US$/Ton) by Type (2024-2034)
Figure 60. Global Sales Market Share of Opioid Analgesics by Application (2024-2034)
Figure 61. Global Revenue Market Share of Opioid Analgesics by Application (2024-2034)
Figure 62. Global Opioid Analgesics Price (US$/Ton) by Application (2024-2034)
Figure 63. Opioid Analgesics Value Chain
Figure 64. Opioid Analgesics Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed